Trimel Pharmaceuticals Shares Outstanding 2012-2020 | ASPCF

Trimel Pharmaceuticals shares outstanding from 2012 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Trimel Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2019 255
2018 224
2017 213
2016 210
2015 201
2014 176
2013 130
2012 87
2011 67
Trimel Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30 1,011
2020-06-30 1,010
2020-03-31 656
2019-12-31 255
2019-09-30 261
2019-06-30 261
2019-03-31 236
2018-12-31 224
2018-09-30 235
2018-06-30 214
2018-03-31 213
2017-12-31 213
2017-09-30 213
2017-06-30 213
2017-03-31 213
2016-12-31 210
2016-09-30 213
2016-06-30 215
2016-03-31 206
2015-12-31 201
2015-09-30 201
2015-06-30 201
2015-03-31 201
2014-12-31 201
2014-09-30 186
2014-06-30 163
2014-03-31 155
2013-12-31 130
2013-09-30 148
2013-06-30 133
2013-03-31 91
2012-12-31 87
2012-09-30 89
2012-06-30 83
2012-03-31 83
2011-12-31 67
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.065B $0.004B
Acerus Pharmaceuticals Corporation is a pharmaceutical company. The company is focused on the development, manufacture, marketing and distribution of branded products which improve the patient experience. The company's product include ESTRACE(R) which provides symptomatic relief of menopausal symptoms and NATESTO(TM) a bioadhesive intranasal gel formulation of testosterone. It also develops Tefina, an intranasal, low-dose gel formulation of testosterone for women experiencing female orgasmic disorder. Acerus Pharmaceuticals Corp, formerly known as Trimel Pharmaceuticals Corp, is headquartered in Mississauga, Canada.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.765B 40.32
Takeda Pharmaceutical (TAK) Japan $52.682B 9.66
Astellas Pharma (ALPMY) Japan $29.537B 18.24
Eisai (ESALY) Japan $20.586B 22.83
Catalent (CTLT) United States $19.356B 51.22
Grifols, S.A (GRFS) Spain $11.180B 12.80
Neurocrine Biosciences (NBIX) United States $10.288B 23.86
Jazz Pharmaceuticals (JAZZ) Ireland $9.465B 15.81
Arrowhead Pharmaceuticals (ARWR) United States $8.268B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.603B 0.00
United Therapeutics (UTHR) United States $7.447B 14.46
Ionis Pharmaceuticals (IONS) United States $7.381B 0.00
IPSEN SA ADR (IPSEY) France $7.175B 0.00
Evotec AG (EVTCY) Germany $6.372B 430.30
Orion OYJ (ORINY) Finland $5.794B 0.00
Sage Therapeutics (SAGE) United States $4.962B 0.00
ChemoCentryx (CCXI) United States $4.695B 0.00
FibroGen (FGEN) United States $4.553B 0.00
Tilray (TLRY) Canada $4.184B 0.00
Nektar Therapeutics (NKTR) United States $4.071B 0.00
PTC Therapeutics (PTCT) United States $3.896B 0.00
Cronos Group (CRON) Canada $3.765B 0.00
Hypermarcas (HYPMY) Brazil $3.659B 14.44
Pacira BioSciences (PCRX) United States $3.193B 54.44
Revolution Medicines (RVMD) United States $3.032B 0.00
Corcept Therapeutics (CORT) United States $2.950B 29.59
Xencor (XNCR) United States $2.855B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.735B 16.94
AlloVir (ALVR) United States $2.380B 0.00
Sundial Growers (SNDL) Canada $2.077B 0.00
USANA Health Sciences (USNA) United States $2.042B 16.56
BioCryst Pharmaceuticals (BCRX) United States $1.903B 0.00
Endo (ENDP) Ireland $1.826B 2.76
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.783B 0.00
Translate Bio (TBIO) United States $1.735B 0.00
ImmunoGen (IMGN) United States $1.704B 0.00
Heron Therapeutics (HRTX) United States $1.652B 0.00
Organogenesis Holdings (ORGO) United States $1.639B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.616B 10.36
Ironwood Pharmaceuticals (IRWD) United States $1.486B 11.68
Ocular Therapeutix (OCUL) United States $1.391B 0.00
Indivior (INVVY) United States $1.316B 0.00
Zogenix (ZGNX) United States $1.181B 0.00
Trillium Therapeutics (TRIL) Canada $1.168B 0.00
Aclaris Therapeutics (ACRS) United States $1.154B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.060B 0.00
Karyopharm Therapeutics (KPTI) United States $1.031B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.995B 0.00
Vectura Group (VEGPF) United Kingdom $0.952B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Radius Health (RDUS) United States $0.873B 0.00
Aerie Pharmaceuticals (AERI) United States $0.861B 0.00
Collegium Pharmaceutical (COLL) United States $0.820B 31.04
VAXART, INC (VXRT) United States $0.783B 0.00
Esperion Therapeutics (ESPR) United States $0.765B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.701B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.701B 0.00
Chinook Therapeutics (KDNY) United States $0.697B 0.00
Altimmune (ALT) United States $0.592B 0.00
KalVista Pharmaceuticals (KALV) United States $0.590B 0.00
Rafael Holdings (RFL) United States $0.588B 0.00
Ardelyx (ARDX) United States $0.582B 0.00
Acutus Medical (AFIB) United States $0.578B 0.00
Summit Therapeutics (SMMT) United States $0.559B 0.00
Molecular Templates (MTEM) United States $0.545B 0.00
Flexion Therapeutics (FLXN) United States $0.543B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.503B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.501B 0.00
Akebia Therapeutics (AKBA) United States $0.500B 0.00
Harpoon Therapeutics (HARP) United States $0.490B 0.00
Siga Technologies (SIGA) United States $0.489B 13.74
AVITA Medical (RCEL) United States $0.470B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.469B 0.00
TherapeuticsMD (TXMD) United States $0.456B 0.00
DURECT (DRRX) United States $0.451B 0.00
PROFOUND MEDICL (PROF) Canada $0.445B 0.00
Jounce Therapeutics (JNCE) United States $0.438B 0.00
MEI Pharma (MEIP) United States $0.422B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.403B 10.51
Redhill Biopharma (RDHL) Israel $0.395B 0.00
VYNE Therapeutics (VYNE) United States $0.383B 0.00
Innate Pharma SA (IPHYF) France $0.356B 0.00
Nature's Sunshine Products (NATR) United States $0.324B 20.86
CASI Pharmaceuticals (CASI) United States $0.305B 0.00
Alpine Immune Sciences (ALPN) United States $0.279B 0.00
Xeris Pharmaceuticals (XERS) United States $0.267B 0.00
Onconova Therapeutics (ONTX) United States $0.258B 0.00
Oncternal Therapeutics (ONCT) United States $0.255B 0.00
Lannett Co Inc (LCI) United States $0.251B 8.42
Jaguar Animal Health (JAGX) United States $0.247B 0.00
CTI BioPharma (CTIC) United States $0.245B 0.00
IMV INC (IMV) Canada $0.223B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.219B 0.00
Concert Pharmaceuticals (CNCE) United States $0.215B 0.00
Novan (NOVN) United States $0.214B 0.00
Calithera Biosciences (CALA) United States $0.206B 0.00
OptiNose (OPTN) United States $0.202B 0.00
Iterum Therapeutics (ITRM) Ireland $0.199B 0.00
Taiwan Liposome (TLC) Taiwan $0.198B 0.00
Qilian Holding Group (QLI) China $0.197B 0.00
Infinity Pharmaceuticals (INFI) United States $0.195B 0.00
Nutriband (NTRB) United States $0.194B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.183B 0.00
Heat Biologics (HTBX) United States $0.182B 0.00
KemPharm (KMPH) United States $0.179B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.171B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.170B 0.00
Aziyo Biologics (AZYO) United States $0.163B 0.00
Genocea Biosciences (GNCA) United States $0.163B 0.00
Champions Oncology (CSBR) United States $0.156B 0.00
Aquestive Therapeutics (AQST) United States $0.154B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.150B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.143B 0.00
Otonomy (OTIC) United States $0.141B 0.00
MediWound (MDWD) Israel $0.139B 0.00
Lipocine (LPCN) United States $0.131B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.116B 0.00
ProPhase Labs (PRPH) United States $0.116B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.104B 0.00
Natural Alternatives (NAII) United States $0.100B 27.09
ElectroCore (ECOR) United States $0.099B 0.00
Assertio Holdings (ASRT) United States $0.097B 0.00
Baudax Bio (BXRX) United States $0.095B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.094B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.084B 0.00
Recro Pharma (REPH) United States $0.081B 0.00
PolarityTE (PTE) United States $0.078B 0.00
Biomerica (BMRA) United States $0.072B 0.00
Addex Therapeutics (ADXN) Switzerland $0.071B 0.00
CV Sciences (CVSI) United States $0.069B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.068B 0.00
Inhibikase Therapeutics (IKT) United States $0.067B 0.00
Brickell Biotech (BBI) United States $0.064B 0.00
Sigyn Therapeutics (SIGY) United States $0.062B 0.00
Plus Therapeutics (PSTV) United States $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 26.15
Regulus Therapeutics (RGLS) United States $0.049B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.043B 0.00
Neos Therapeutics (NEOS) United States $0.042B 0.00
RXi Pharmaceuticals (PHIO) United States $0.040B 0.00
Mannatech (MTEX) United States $0.037B 5.47
China SXT Pharmaceuticals (SXTC) China $0.030B 0.00
Midatech Pharma (MTP) United Kingdom $0.029B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.026B 0.00
Cyanotech (CYAN) United States $0.023B 19.00
Bellicum Pharmaceuticals (BLCM) United States $0.022B 0.00
JanOne (JAN) United States $0.020B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.015B 0.00
SHINECO INC (TYHT) China $0.013B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00